Loading clinical trials...
Loading clinical trials...
Feasibility of Cetuximab (ERBITUX®) Associated With Concomitant Radio-chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer: a Phase II, Randomised Study
Conditions
Interventions
cisplatin, vinorlebine, cetuximab
cisplatine, etoposide, cetuximab
Locations
1
France
Institut de Cancerologie de la Loire
Saint-Priest-en-Jarez, France
Start Date
September 1, 2009
Primary Completion Date
August 1, 2011
Completion Date
August 1, 2011
Last Updated
September 14, 2017
NCT06487078
NCT06461338
NCT04738487
NCT04990479
NCT03950674
NCT03770299
Lead Sponsor
Institut de Cancérologie de la Loire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions